Talecris Biotherapeutics

  Home About Talecris Therapeutic Areas Research & Development Donor to Patient Media Center Talecris Careers  
About Talecris Biotherapeutics
The History of Talecris
Talecris Leadership
The Talecris Commitment
Corporate Governance & Compliance
Talecris Locations

Product Sites


View by Product

Talecris discovers, develops and produces protein therapies for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonary and critical care, coagulation and thrombosis

Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition, approved indications (uses), product labels, and packaging for a prescription drug may differ between countries. Please refer to the prescribing information provided for your country of residence.

US flag United States

Gamunex®, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified
Hypermunes Hyperimmune Globulin Therapy
Koate®-DVI, Antihemophilic Factor (Human)
Plasbumin®, Albumin (Human) and Plasmanate®, Plasma Protein Fraction (Human)
Prolastin®, Alpha1- Proteinase Inhibitor (Human)
Thrombate III®, Antithrombin III (Human)

 

Canada flag  Canada

Gamunex®, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified
Hypermunes Hyperimmune Globulin Therapy
Plasbumin®, Albumin (Human) and Plasmanate®, Plasma Protein Fraction (Human)
Prolastin®, Alpha1- Proteinase Inhibitor (Human)

 

Germany flag Germany

Gamunex®, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified
Prolastin®, Alpha1- Proteinase Inhibitor (Human)

 

 

 

Print This Page
E-mail This Page
Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2008 Talecris Biotherapeutics